A Pedigree with Pulmonary Alveolar Microlithiasis: A Clinical Case Report and Literature Review

Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive disease characterized by the presence of innumerable calcium phosphate microliths in the alveoli. Clinical-radiological dissociation is an important hallmark of this disease. Most PAM patients are asymptomatic and pulmonary tissue...

Full description

Saved in:
Bibliographic Details
Published inCell biochemistry and biophysics Vol. 70; no. 1; pp. 565 - 572
Main Authors Ma, Tiangang, Ren, Jin, Yin, Jinzhi, Ma, Zhongsen
Format Journal Article
LanguageEnglish
Published Boston Springer US 01.09.2014
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive disease characterized by the presence of innumerable calcium phosphate microliths in the alveoli. Clinical-radiological dissociation is an important hallmark of this disease. Most PAM patients are asymptomatic and pulmonary tissue changes are discovered incidentally. PAM is pathologically attributable to the formation and aggregation of calcium phosphate microliths in the alveoli after mutations in the SLC34A2 gene (the type IIb sodium-phosphate cotransporter gene) coding NaPi-IIb. In the clinical work, we discovered an inbred pedigree with PAM, which include four PAM siblings. We performed a sequence analysis of the SLC34A2 gene in all members of this PAM pedigree and found that a homozygous mutation c.575C > A (p.T192 K) in exon 6 was involved. To the best of our knowledge, this study was the first to discover nucleotide mutations in exon 6 in Asians.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1085-9195
1559-0283
DOI:10.1007/s12013-014-9957-9